Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Fish and Richardson
Accenture
Harvard Business School
Novartis
Healthtrust
Argus Health
US Department of Justice
Covington
Moodys

Generated: August 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202379

« Back to Dashboard
NDA 202379 describes ZYTIGA, which is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the ZYTIGA profile page.

The generic ingredient in ZYTIGA is abiraterone acetate. There are twenty-three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the abiraterone acetate profile page.

Summary for NDA: 202379

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:2
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 202379

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZYTIGA
abiraterone acetate
TABLET;ORAL 202379 NDA Janssen Biotech, Inc. 57894-150 57894-150-12 120 TABLET in 1 BOTTLE (57894-150-12)
ZYTIGA
abiraterone acetate
TABLET;ORAL 202379 NDA Janssen Biotech, Inc. 57894-184 57894-184-12 120 TABLET, FILM COATED in 1 BOTTLE (57894-184-12)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Apr 28, 2011TE:RLD:Yes
Patent:► SubscribePatent Expiration:Dec 13, 2016Product Flag?YSubstance Flag?YDelist Request?
Patented Use:USE IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Patent:► SubscribePatent Expiration:Aug 24, 2027Product Flag?Substance Flag?Delist Request?
Patented Use:USE IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Patent:► SubscribePatent Expiration:Aug 24, 2027Product Flag?Substance Flag?Delist Request?
Patented Use:USE IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHO HAD RECEIVED PRIOR DOCETAXEL CHEMOTHERAPY

Expired Orange Book Patents for NDA: 202379

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Biotech
ZYTIGA
abiraterone acetate
TABLET;ORAL202379-001Apr 28, 2011► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
AstraZeneca
Farmers Insurance
Harvard Business School
Cipla
Cerilliant
Daiichi Sankyo
Chinese Patent Office
Johnson and Johnson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot